BMT and no vaccine-related serious adverse events occurred. Neither allo or autologous transplant recipients had demonstrable antibodies against pertussis 1 year following BMT and immunogenicity of the pertussis component of Tdap was poor, even following 3 doses, despite good immune responses to Td. While a correlate of protection from pertussis is not known, observed responses to Tdap following both allo and auto BMT raise concern that even a 3-dose series of Tdap may not provide full protection in this population. Further studies are needed to establish optimal immunization timing and schedule of Tdap required to ensure protection in this vulnerable population.
BMT and no vaccine-related serious adverse events occurred. Neither allo or autologous transplant recipients had demonstrable antibodies against pertussis 1 year following BMT and immunogenicity of the pertussis component of Tdap was poor, even following 3 doses, despite good immune responses to Td. While a correlate of protection from pertussis is not known, observed responses to Tdap following both allo and auto BMT raise concern that even a 3-dose series of Tdap may not provide full protection in this population. Further studies are needed to establish optimal immunization timing and schedule of Tdap required to ensure protection in this vulnerable population. (table 1) . Diagnosis was confirmed in 3/6 by detection of VZV in CSF by PCR. All other patients had a clinical diagnosis based on the presence of CNS symptoms, zoster, lymphocytic pleiocytosis, and response to IV acyclovir. Patients who developed CNS disease had a mean age of 42 years (range 34-51) at time of transplant. CNS disease developed at a mean of 9 months posttransplantation (range 0.5-24 months), and severity varied, ranging from meningitis (3/6) to encephalitis/myelitis (3/6). All had active graft-versus host disease (GHVD) and all were being treated with immunosuppressive therapy at time of diagnosis. Fever and headache were the most common symptoms, but patients who developed focal CNS findings or seizures (3/6) had a more complicated clinical course. While most patients presented with classic Objective: The aim of the research was a detailed study and analysis of current data and trends of HIV/AIDS epidemiology in one of the largest areas in Central Russia in order to show the growing need for treatment and palliative care for people living with HIV/AIDS in the region.
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Methods:
We studied the official demographical data and the HIV/AIDS epidemiology data provided by the regional AIDS Centre within the entire period of epidemic and compared it with the official federal statistics. The most recent and negative trend is the proportion of women infected which has been increasing. In 2006, the proportion of women among newly diagnosed HIV cases was 43.7%. As a result, there is an increase in the potential for a growing mother-to-child HIV transmission. The problem is becoming worse as HIV spreads more widely from vulnerable groups into the general population. Conclusion: This study demonstrates the major trends in HIV/AIDS epidemic progression and can be used for making estimates and helping policymakers to determine the impact of specific programs in the region.
